Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease
The International Organization for the Study of Inflammatory Bowel Disease (IOIBD) aimed to identify a set of endpoints that can be used to determine the efficacy of anti-fibrosis drugs.
